Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q3 2022 · 10-Q
Revenue$54.70M$54.70M+60.1% vs Q3 2021 Net Income-$2.06M-$2.06MN/M vs Q3 2021 EPS Diluted-$0.39-$0.39N/M vs Q3 2021 Gross Profit$28,627,000+38.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$15,898,000+45.3% Free Cash Flowderived$13,839,000+29.4% Margins · derivedGross margin52.3%−8.1 pt vs Q3 2021
Operating margin-4.6%−4.7 pt vs Q3 2021
Net margin-3.8%+9.5 pt vs Q3 2021
ended Dec 31, 2021 · filed Feb 3, 2022 · 34 d after period end